Your browser doesn't support javascript.
loading
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.
Blumenthal, Gideon M; Bunn, Paul A; Chaft, Jamie E; McCoach, Caroline E; Perez, Edith A; Scagliotti, Giorgio V; Carbone, David P; Aerts, Hugo J W L; Aisner, Dara L; Bergh, Jonas; Berry, Donald A; Jarkowski, Anthony; Botwood, Nicholas; Cross, Darren A E; Diehn, Max; Drezner, Nicole L; Doebele, Robert C; Blakely, Collin M; Eberhardt, Wilfried E E; Felip, Enriqueta; Gianni, Luca; Keller, Steven P; Leavey, Patrick J; Malik, Shakun; Pignatti, Francesco; Prowell, Tatiana M; Redman, Mary W; Rizvi, Naiyer A; Rosell, Rafael; Rusch, Valerie; de Ruysscher, Dirk; Schwartz, Lawrence H; Sridhara, Rajeshwari; Stahel, Rolf A; Swisher, Stephen; Taube, Janis M; Travis, William D; Keegan, Patricia; Wiens, Jacinta R; Wistuba, Ignacio I; Wynes, Murry W; Hirsch, Fred R; Kris, Mark G.
Afiliação
  • Blumenthal GM; Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland. Electronic address: gideon.blumenthal@fda.hhs.gov.
  • Bunn PA; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado.
  • Chaft JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • McCoach CE; Department of Medicine, University of California, San Francisco, California; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Perez EA; Hematology and Oncology, Mayo Clinic, Rochester, Minnesota.
  • Scagliotti GV; Medical Oncology Division, Department of Oncology at San Luigi Hospital, University of Torino, Orbassano, Italy.
  • Carbone DP; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio.
  • Aerts HJWL; Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Department of Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Aisner DL; Department of Pathology, University of Colorado, Aurora, Colorado.
  • Bergh J; Department of Oncology-Pathology, Cancer Centrum Karolinska, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden.
  • Berry DA; Berry Consultants, LLC, Austin, Texas; University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jarkowski A; Oncology Clinical Development, Bristol-Myers Squibb, Lawrenceville, New Jersey.
  • Botwood N; Thoracic Cancers, Bristol-Myers Squibb, Lawrenceville, New Jersey.
  • Cross DAE; AstraZeneca Oncology Innovative Medicines, Alderley Park, Macclesfield, Cheshire, United Kingdom.
  • Diehn M; Department of Radiation Oncology, Stanford Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.
  • Drezner NL; Brain Tumor Institute, Children's National Health System, Children's National Medical Center, Washington, DC; Office of Hematology Oncology Products, Food and Drug Administration, Silver Spring, Maryland.
  • Doebele RC; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado.
  • Blakely CM; Department of Medicine, University of California, San Francisco, California; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Eberhardt WEE; Department of Medical Oncology, West German Cancer Centre, University Hospital, University Duisburg-Essen, Ruhrlandklinik, Essen, Germany.
  • Felip E; Medical Oncology Department, Vall d' Hebron University Hospital, Vall d' Hebron Institute of Oncology, Barcelona, Spain.
  • Gianni L; Department of Medical Oncology, Ospedale San Raffaele, Milan, Italy.
  • Keller SP; Merck, Rahway, New Jersey.
  • Leavey PJ; Children's Health Children's Medical Center Dallas, Texas; University of Texas Southwestern Medical Center, Dallas, Texas.
  • Malik S; Cancer Therapeutics Evaluation Program, Rockville, Maryland.
  • Pignatti F; European Medicines Agency, London, United Kingdom.
  • Prowell TM; Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland; Breast Cancer Program, Johns Hopkins Kimmel Comprehensive Cancer Center Baltimore, Maryland.
  • Redman MW; Southwest Oncology Group Statistical Center/Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Rizvi NA; Division of Hematology and Oncology, Columbia University Medical Center, New York, New York.
  • Rosell R; Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Barcelona, Spain.
  • Rusch V; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • de Ruysscher D; KU Leuven-University of Leuven, Department of Radiation Oncology, Leuven, Belgium; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Centre, GROW, Maastricht, The Netherlands.
  • Schwartz LH; Department of Radiology, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, New York.
  • Sridhara R; Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland.
  • Stahel RA; Comprehensive Cancer Center, Zürich, Switzerland.
  • Swisher S; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Taube JM; Johns Hopkins School of Medicine, Department of Dermatology, Division of Dermatopathology, Baltimore, Maryland.
  • Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Keegan P; Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland.
  • Wiens JR; International Association for the Study of Lung Cancer, Aurora, Colorado.
  • Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wynes MW; International Association for the Study of Lung Cancer, Aurora, Colorado.
  • Hirsch FR; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado; International Association for the Study of Lung Cancer, Aurora, Colorado.
  • Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell School of Medicine, New York, New York.
J Thorac Oncol ; 13(12): 1818-1831, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30268698
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article